Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is a common malignancy with high morbidity and mortality worldwide. To date, chemotherapy plays an important role in the treatment of CRC patients. Multidrug resistance (MDR) is one of the major hurdles in chemotherapy for CRC, and the underlying mechanisms need to be explored. Studies have demonstrated that Wnt/β‐catenin signaling plays a critical role in oncogenesis and tumor development, and its function in inhibiting apoptosis could facilitate tumor chemoresistance. Recent investigations have also suggested the regulatory effects of the Wnt/β‐catenin signaling pathway in response to chemotherapeutic agents in CRC. Here, we particularly focus on reviewing the evidences suggesting the mechanisms of Wnt/β‐catenin signaling in the chemoresistance modulation of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current studies have shown that activation of the Wnt/β-catenin signaling pathway can mediate CRC resistance to chemotherapy through several pathways, such as upregulation of MDR1, inhibition of apoptosis, maintenance of stem cell dryness, regulation of epithelial-mesenchymal transformation (EMT) and regulation of tumor microenvironment [191].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Li, T., Guo, H., Song, Y., Zhao, X., Shi, Y., Lu, Y., Hu, S., Nie, Y., Fan, D., & Wu, K. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-263 · Cited by 82 · cited 10×
“It has been proven that Wnt/β-catenin signaling modulates the expression of CSC marker genes and plays a role in the self-renewal ability and undifferentiated status of CSCs [43–45].”
BackgroundInfluentialRetractedDermani, F. K., Amini, R., Saidijam, M., Pourjafar, M., Saki, S., & Najafi, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26874 · Cited by 45 · cited 1×
“It was also observed that zerumbone could suppress the stemness properties of CRC by inhibiting the β-catenin signaling pathway [52].”
BackgroundRetractedMiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
Fan, H., Liu, X., Zheng, W.-W., Zhuang, Z.-H., & Wang, C.-D. (2017) · PubMed · doi:10.26355/eurrev_202007_22181 · Cited by 26 · cited 1×
“They have been increasingly implicated in the regulation of cell stemness and EMT, which contribute to drug resistance in colorectal cancer [83, 84].”
BackgroundRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 1×
“Colorectal cancer (CRC), one of the most prevalent malignancies, ranked third in cancer incidence in both genders and remains the second cause of cancer-related deaths in the world [1].”
BackgroundThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“In CRC, loss of E-cadherin is concomitant with the deregulation of the Wnt/β-catenin signaling pathway and has been characterized as a trait of EMT cells [71].”
BackgroundThe Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672 · cited 1×
“differentiate into heterogeneous cell lineages that constitute the tumor [34, 35].”
BackgroundComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · cited 2×
“Wnt/β-catenin signaling pathway is found altered in more than 90% CRC patients, making it a crucial therapeutic target [11].”
BackgroundEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628 · cited 1×
“EMT is a process that allows epithelial cells to undergo remarkable morphologic changes to assume a migratory mesenchymal phenotype characterized by loss of apical basolateral polarity and cell-cell adhesion [56, 57].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958 · cited 2×
“As one of the major signaling pathways involved in EMT, Wnt/β-catenin signaling converging on activation of transcription factors such as ZEB and Snail was triggered to induce the expression of mesenchymal genes and repress E-cadherin expression [57, 66].”
Background
Research works printed but not linked: 1
- 10.1186/s13046-014-0107-4 · doi:10.1186/s13046-014-0107-4 · Paper page
Cited by
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
“Studies have shown that Wnt/−catenin signaling plays a key role in tumorigenesis and tumor development, and its function of inhibiting cell apoptosis can promote tumor chemoresistance [38].”
BackgroundDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
DeRango-Adem, E. F., & Blay, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681477 · Cited by 126
“This pathway regulates cellular behaviors including migration and the formation of tissue structures, and plays a key role in both the formation and progression of cancers, including colorectal carcinoma (Yuan et al., 2020; Bugter et al., 2021; Caspi et al., 2021).”
BackgroundZhang, L., Li, C., & Su, X. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01784-8 · Cited by 96
Zhang, Q., Yang, X., Wu, J., Ye, S., Gong, J., Cheng, W. M., Luo, Z., Yu, J., Liu, Y., Zeng, W., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00515-x · Cited by 102
Metadata
- Authors
- Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X., & Wu, D.
- Affiliations
- Qingdao Municipal Hospital (CN)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wu, Dapeng
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 2020
- Issue
- 1
- Pages
- 9390878-9390878
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC7109575
- OpenAlex
- W3012199016
- Cited by
- 131
- References
- 94
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 17 · 2023: 22 · 2022: 26 · 2021: 21 · 2020: 9
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Science and Technology Commission of Qingdao Municipality (KJZD-13-39-JCH)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- Wnt/β-catenin signaling, colorectal cancer, chemoresistance, multidrug resistance, apoptosis inhibition, anticancer agents, carcinogenesis
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasm Proteins, Colorectal Neoplasms, Drug Resistance, Neoplasm, beta Catenin, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer. https://app.cochat.ai/papers/10.1155/2020/9390878
- The paper
- Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X., & Wu, D. (2020). Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer. BioMed Research International. https://doi.org/10.1155/2020/9390878
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
